From Bloomberg News
An experimental cancer drug made by Sanofi-Aventis SA helped patients with
advanced breast tumors live more than 60 percent longer using a new method that
stops diseased cells from healing themselves, a new study found.
...
Sanofi will begin enrolling 400 patients in the next two months for an
expanded trial to confirm the results.
(
Read more... )